Skip to main content
Top
Published in: Indian Journal of Hematology and Blood Transfusion 1/2014

01-09-2014 | Case Report

Fanconi Anemia with MDS RAEB-2 Rapidly Progressing to AML in a 5-Year-Old Boy

Authors: H. Rama, Devika Gupta, Tathagata Chatterjee, Srishti Gupta

Published in: Indian Journal of Hematology and Blood Transfusion | Special Issue 1/2014

Login to get access

Abstract

Fanconi’s Anemia is primarily an autosomal recessive genetic disorder characterized by congenital abnormalities, defective haematopoiesis leading to bone marrow failure and increased risk of development of Myelodysplastic syndrome, acute myeloid leukemia and solid tumours. Chromosomal instability can be demonstrated by breakage caused by alkylating agents and forms the basis of diagnosis. Our patient presented with structural deformities associated with features of bone marrow failure in form of pancytopenia. Bone marrow analysis and flow cytometry done on aspirate was suggestive of MDS. He subsequently progressed to frank acute myeloid leukemia and succumbed to the illness. The case is being reported for its rarity especially, Fanconi’s Anemia associated with monosomal karyotype (one monosomy plus one more structural abnormality).
Literature
2.
go back to reference Auerbach AD, Buchwald M, Joenje H (2001) Fanconi anemia. In: Scriver CR, Sly WS, Childs B et al (eds) The metabolic and molecular bases of inherited disease, vol 1, 8th ed. McGraw-Hill, New York, pp. 753–768 Auerbach AD, Buchwald M, Joenje H (2001) Fanconi anemia. In: Scriver CR, Sly WS, Childs B et al (eds) The metabolic and molecular bases of inherited disease, vol 1, 8th ed. McGraw-Hill, New York, pp. 753–768
3.
go back to reference Alter BP (2003) Inherited bone marrow failure syndromes. In: Nathan DG, Orkin SH, Ginsburg D, Look AT (eds) Nathan and Oski’s hematology of infancy and childhood, vol 1, 6th ed. Saunders, Philadelphia, pp. 280–365 Alter BP (2003) Inherited bone marrow failure syndromes. In: Nathan DG, Orkin SH, Ginsburg D, Look AT (eds) Nathan and Oski’s hematology of infancy and childhood, vol 1, 6th ed. Saunders, Philadelphia, pp. 280–365
4.
go back to reference Auerbach AD (1993) Fanconi anemia diagnosis and the diepoxybutane (DEB) test. Exp Hematol 21:731–733PubMed Auerbach AD (1993) Fanconi anemia diagnosis and the diepoxybutane (DEB) test. Exp Hematol 21:731–733PubMed
5.
go back to reference Kutler DI, Singh B, Satagopan J et al (2003) A 20-year perspective on the International Fanconi Anemia Registry (IFAR). Blood 101:1249–1256PubMedCrossRef Kutler DI, Singh B, Satagopan J et al (2003) A 20-year perspective on the International Fanconi Anemia Registry (IFAR). Blood 101:1249–1256PubMedCrossRef
7.
go back to reference Rochowski A, Olson SB, Alonzo TA et al (2012) Patients with Fanconi anemia and AML have different cytogenetic clones than de novo cases of AML. Pediatr Blood Cancer 59(5):922–924PubMedCrossRefPubMedCentral Rochowski A, Olson SB, Alonzo TA et al (2012) Patients with Fanconi anemia and AML have different cytogenetic clones than de novo cases of AML. Pediatr Blood Cancer 59(5):922–924PubMedCrossRefPubMedCentral
8.
go back to reference Tonnies H, Huber S, Kuhl JS et al (2003) Clonal chromosome aberrations in bone marrow cells of Fanconi anemia patients: gains of the chromosomal segment 3q26q29 as an adverse risk factor. Blood 101:3872–3874PubMedCrossRef Tonnies H, Huber S, Kuhl JS et al (2003) Clonal chromosome aberrations in bone marrow cells of Fanconi anemia patients: gains of the chromosomal segment 3q26q29 as an adverse risk factor. Blood 101:3872–3874PubMedCrossRef
9.
go back to reference Tischkowitz M, Dokal I (2004) Fanconi anaemia and leukaemia— clinical and molecular aspects. Br J Haematol 126:176–191PubMedCrossRef Tischkowitz M, Dokal I (2004) Fanconi anaemia and leukaemia— clinical and molecular aspects. Br J Haematol 126:176–191PubMedCrossRef
10.
go back to reference Rosenberg PS, Alter BP, Socie G et al (2005) Secular trends in outcomes for Fanconi anemia patients who receive transplants: implications for future studies. Biol Blood Marrow Transplant 11:672–679PubMedCrossRef Rosenberg PS, Alter BP, Socie G et al (2005) Secular trends in outcomes for Fanconi anemia patients who receive transplants: implications for future studies. Biol Blood Marrow Transplant 11:672–679PubMedCrossRef
11.
go back to reference Croop JM (2003) Gene therapy for Fanconi anemia. Curr Hematol Rep 2:335–340PubMed Croop JM (2003) Gene therapy for Fanconi anemia. Curr Hematol Rep 2:335–340PubMed
Metadata
Title
Fanconi Anemia with MDS RAEB-2 Rapidly Progressing to AML in a 5-Year-Old Boy
Authors
H. Rama
Devika Gupta
Tathagata Chatterjee
Srishti Gupta
Publication date
01-09-2014
Publisher
Springer India
Published in
Indian Journal of Hematology and Blood Transfusion / Issue Special Issue 1/2014
Print ISSN: 0971-4502
Electronic ISSN: 0974-0449
DOI
https://doi.org/10.1007/s12288-014-0424-y

Other articles of this Special Issue 1/2014

Indian Journal of Hematology and Blood Transfusion 1/2014 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine